Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 27 of 27 entries
Sorted by: Best Match Show Resources per page
Value of intraoperative monitoring of the trigeminal nerve in detection of a superiorly displaced facial nerve during surgery for large vestibular schwannomas.

Neurosurgical review

Ashram YA, Zohdy YM, Rayan TA, Badr-El-Dine MMK.
PMID: 34533668
Neurosurg Rev. 2021 Sep 17; doi: 10.1007/s10143-021-01646-7. Epub 2021 Sep 17.

The aim of this study was to investigate the role of trigeminal and facial nerve monitoring in the early identification of a superiorly (anterior and superior (AS)) displaced facial nerve. This prospective study included 24 patients operated for removal...

Cite
Ashram YA, Zohdy YM, Rayan TA, et al. Value of intraoperative monitoring of the trigeminal nerve in detection of a superiorly displaced facial nerve during surgery for large vestibular schwannomas. Neurosurg Rev. 2021;doi: 10.1007/s10143-021-01646-7.
Ashram, Y. A., Zohdy, Y. M., Rayan, T. A., & Badr-El-Dine, M. M. K. (2021). Value of intraoperative monitoring of the trigeminal nerve in detection of a superiorly displaced facial nerve during surgery for large vestibular schwannomas. Neurosurgical review, . https://doi.org/10.1007/s10143-021-01646-7
Ashram, Yasmine A, et al. "Value of intraoperative monitoring of the trigeminal nerve in detection of a superiorly displaced facial nerve during surgery for large vestibular schwannomas." Neurosurgical review vol. (2021). doi: https://doi.org/10.1007/s10143-021-01646-7
Ashram YA, Zohdy YM, Rayan TA, Badr-El-Dine MMK. Value of intraoperative monitoring of the trigeminal nerve in detection of a superiorly displaced facial nerve during surgery for large vestibular schwannomas. Neurosurg Rev. 2021 Sep 17; doi: 10.1007/s10143-021-01646-7. Epub 2021 Sep 17. PMID: 34533668.
Copy Download .nbib Format: NLM
Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells.

Pharmaceuticals (Basel, Switzerland)

Alhakamy NA, Badr-Eldin SM, Alharbi WS, Alfaleh MA, Al-Hejaili OD, Aldawsari HM, Eid BG, Bakhaidar R, Drago F, Caraci F, Caruso G.
PMID: 34959710
Pharmaceuticals (Basel). 2021 Dec 15;14(12). doi: 10.3390/ph14121309.

Pancreatic cancer currently represents a severe issue for the entire world. Therefore, much effort has been made to develop an effective treatment against it. Emerging evidence has shown that icariin, a flavonoid glycoside, is an effective anti-pancreatic cancer drug....

Cite
Alhakamy NA, Badr-Eldin SM, Alharbi WS, et al. Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells. Pharmaceuticals (Basel). 2021;14(12)doi: 10.3390/ph14121309.
Alhakamy, N. A., Badr-Eldin, S. M., Alharbi, W. S., Alfaleh, M. A., Al-Hejaili, O. D., Aldawsari, H. M., Eid, B. G., Bakhaidar, R., Drago, F., Caraci, F., & Caruso, G. (2021). Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells. Pharmaceuticals (Basel, Switzerland), 14(12), . https://doi.org/10.3390/ph14121309
Alhakamy, Nabil A, et al. "Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells." Pharmaceuticals (Basel, Switzerland) vol. 14,12 (2021). doi: https://doi.org/10.3390/ph14121309
Alhakamy NA, Badr-Eldin SM, Alharbi WS, Alfaleh MA, Al-Hejaili OD, Aldawsari HM, Eid BG, Bakhaidar R, Drago F, Caraci F, Caruso G. Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells. Pharmaceuticals (Basel). 2021 Dec 15;14(12). doi: 10.3390/ph14121309. PMID: 34959710.
Copy Download .nbib Format: NLM
Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against .

Pharmaceutics

Alhakamy NA, Al-Rabia MW, Md S, Sirwi A, Khayat SS, AlOtaibi SS, Hakami RA, Al Sadoun H, Eldakhakhny BM, Abdulaal WH, Aldawsari HM, Badr-Eldin SM, Elfaky MA.
PMID: 34203359
Pharmaceutics. 2021 Jun 28;13(7). doi: 10.3390/pharmaceutics13070977.

Luliconazole is a new topical imidazole antifungal drug for the treatment of skin infections. It has low solubility and poor skin penetration which limits its therapeutic applications. In order to improve its therapeutic efficacy, spanlastics nanoformulation was developed and...

Cite
Alhakamy NA, Al-Rabia MW, Md S, et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against . Pharmaceutics. 2021;13(7)doi: 10.3390/pharmaceutics13070977.
Alhakamy, N. A., Al-Rabia, M. W., Md, S., Sirwi, A., Khayat, S. S., AlOtaibi, S. S., Hakami, R. A., Al Sadoun, H., Eldakhakhny, B. M., Abdulaal, W. H., Aldawsari, H. M., Badr-Eldin, S. M., & Elfaky, M. A. (2021). Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against . Pharmaceutics, 13(7), . https://doi.org/10.3390/pharmaceutics13070977
Alhakamy, Nabil A, et al. "Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against ." Pharmaceutics vol. 13,7 (2021). doi: https://doi.org/10.3390/pharmaceutics13070977
Alhakamy NA, Al-Rabia MW, Md S, Sirwi A, Khayat SS, AlOtaibi SS, Hakami RA, Al Sadoun H, Eldakhakhny BM, Abdulaal WH, Aldawsari HM, Badr-Eldin SM, Elfaky MA. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against . Pharmaceutics. 2021 Jun 28;13(7). doi: 10.3390/pharmaceutics13070977. PMID: 34203359; PMCID: PMC8309172.
Copy Download .nbib Format: NLM
Showing 25 to 27 of 27 entries